N52.37 Erectile dysfunction following prostate ablative therapy

Name of the Condition

• Erectile dysfunction following prostate ablative therapy (ICD-10-CM Code: N52.37)

Summary

Erectile dysfunction following prostate ablative therapy refers to the inability to achieve or maintain an erection sufficient for sexual intercourse after a procedure designed to destroy or remove prostate tissue, such as ablation or other targeted therapies. This condition may result from procedural effects on erectile function, including nerve or vascular changes, and can impact sexual health and quality of life.

Causes

Erectile dysfunction following prostate ablative therapy may arise from damage to nerves, blood vessels, or tissues involved in erectile function during the procedure. Ablative therapies, which aim to treat prostate conditions, can disrupt the normal physiological processes required for achieving or maintaining an erection.

Risk Factors

• Type of ablative procedure performed, especially those involving pelvic or prostate structures.
• Pre-existing erectile function prior to the procedure.
• Age, with older individuals potentially at higher risk.
• Underlying health conditions that may affect recovery or vascular health.

Symptoms

• Inability to achieve or maintain an erection firm enough for sexual intercourse.
• Reduced sexual desire or interest, though this may vary by individual.
• Feelings of distress or frustration related to sexual performance.

Diagnosis

Diagnosis involves a review of the patient’s medical history, including the prostate ablative therapy, and a physical examination. Healthcare providers may assess underlying conditions or contributing factors to determine the cause of dysfunction.

Treatment Options

Treatment may include medications to improve erectile function, such as phosphodiesterase type 5 inhibitors, or other therapies like vacuum erection devices, penile injections, or implants. Counseling or psychological support may also be recommended to address emotional or relational impacts.

Prognosis and Follow-Up

Prognosis varies depending on the extent of nerve or vascular damage and individual response to treatment. Regular follow-up with a healthcare provider is important to monitor erectile function and adjust treatment as needed.

Complications

Potential complications include persistent erectile dysfunction, reduced sexual satisfaction, and emotional distress. In some cases, additional interventions may be required to manage symptoms.

Lifestyle & Prevention

Maintaining overall health through regular exercise, a balanced diet, and managing underlying conditions like diabetes or hypertension may support erectile function. Avoiding smoking and excessive alcohol use can also be beneficial.

When to Seek Professional Help

Seek medical attention if erectile dysfunction persists or worsens, or if it causes significant distress or impacts quality of life. A healthcare provider can evaluate the condition and recommend appropriate management.

Tips for Medical Coders

When coding for N52.37, ensure documentation specifies the type of prostate ablative therapy performed and confirms the erectile dysfunction is a direct result of the procedure. Include details about the timing of symptom onset relative to the therapy for accurate coding.